These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 24852117

  • 1. BINGO: targeted therapy for advanced biliary-tract cancer.
    Valle JW.
    Lancet Oncol; 2014 Jul; 15(8):778-80. PubMed ID: 24852117
    [No Abstract] [Full Text] [Related]

  • 2. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
    Malka D, Cervera P, Foulon S, Trarbach T, de la Fouchardière C, Boucher E, Fartoux L, Faivre S, Blanc JF, Viret F, Assenat E, Seufferlein T, Herrmann T, Grenier J, Hammel P, Dollinger M, André T, Hahn P, Heinemann V, Rousseau V, Ducreux M, Pignon JP, Wendum D, Rosmorduc O, Greten TF, BINGO investigators.
    Lancet Oncol; 2014 Jul; 15(8):819-28. PubMed ID: 24852116
    [Abstract] [Full Text] [Related]

  • 3. Time to move to targeted drugs in biliary tract cancer?
    Louvet C, Tournigand C.
    Onkologie; 2010 Jul; 33(1-2):10-1. PubMed ID: 20164655
    [No Abstract] [Full Text] [Related]

  • 4. Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer.
    Chang PY, Cheng MF, Lee HS, Hsieh CB, Yao NS.
    Onkologie; 2010 Jul; 33(1-2):45-7. PubMed ID: 20164661
    [Abstract] [Full Text] [Related]

  • 5. Response to cetuximab and gemcitabine-oxaliplatin in an advanced case of intrahepatic cholangiocarcinoma.
    Bralet MP, Bellin MF, Guettier C, Adam R, Paule B.
    Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):426. PubMed ID: 16817335
    [No Abstract] [Full Text] [Related]

  • 6. Biliary Tract Cancers: Finding Better Ways to Lump and Split.
    Kelley RK, Bardeesy N.
    J Clin Oncol; 2015 Aug 20; 33(24):2588-90. PubMed ID: 26195717
    [No Abstract] [Full Text] [Related]

  • 7. Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma.
    Law LY.
    J Clin Oncol; 2012 Sep 20; 30(27):e271-3. PubMed ID: 22851567
    [No Abstract] [Full Text] [Related]

  • 8. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J, Okusaka T, Ohkawa S, Nagase M, Funakoshi A, Boku N, Yamao K, Yamaguchi T, Sato T.
    Cancer Chemother Pharmacol; 2009 Dec 20; 65(1):113-20. PubMed ID: 19404641
    [Abstract] [Full Text] [Related]

  • 9. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
    Furuse J, Okusaka T, Funakoshi A, Yamao K, Nagase M, Ishii H, Nakachi K, Ueno H, Ikeda M, Morizane C, Horikawa Y, Mizuno N.
    Jpn J Clin Oncol; 2006 Sep 20; 36(9):552-6. PubMed ID: 16887837
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma.
    Yashima Y, Sato S, Kawai T, Sugimoto T, Sato T, Kanda M, Obi S.
    Hepatol Int; 2015 Jan 20; 9(1):142-8. PubMed ID: 25788388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Systemic therapy for hepatocellular carcinoma and cholangiocarcinoma.
    Chung V.
    Surg Oncol Clin N Am; 2015 Jan 20; 24(1):187-98. PubMed ID: 25444475
    [Abstract] [Full Text] [Related]

  • 15. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
    Guan YS, Qing He, Ping Li, Fu YC, Zhao SW.
    Integr Cancer Ther; 2008 Mar 20; 7(1):51-3. PubMed ID: 18292595
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Regional chemotherapy in experimental cholangiocarcinoma in pigs].
    Dufek V, Petrtýl J.
    Cas Lek Cesk; 1998 Aug 03; 137(15):464-6. PubMed ID: 9748745
    [Abstract] [Full Text] [Related]

  • 18. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
    Chen WX, Li GX, Hu ZN, Zhu P, Zhang BX, Ding ZY.
    Medicine (Baltimore); 2019 Nov 03; 98(45):e17832. PubMed ID: 31702638
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cholangiocarcinoma.
    Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R.
    Crit Rev Oncol Hematol; 2017 Aug 03; 116():11-31. PubMed ID: 28693792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.